Treatment:
Surgical management -
Stereotactic Aspiration: This minimally invasive procedure involved
using image guidance to precisely locate and aspirate (remove) the
abscess with a needle. Abscess Cavity Drainage: After the abscess is
drained or aspirated, a drainage catheter was left in place to continue
removing any residual fluid. Close Monitoring: Patients should be
closely monitored post-surgery for any complications and to ensure that
the infection is responding to treatment. Aspirated material was sent
for microbiological evaluation; the report detected tuberculosis
bacterium on Ziehl–Neelsen (ZN) stain with no evidence of malignancy.
Medical management -
The standard treatment regimen for drug-susceptible TB; isoniazid (INH)
5 mg/kg/d, rifampicin (RMP) 10 mg/kg/d, pyrazinamide (PZA) 25 mg/kg/d,
and ethambutol (ETB) 15 mg/kg/d, were given to the patient during the
intensive phase (IP) for 2 months. Continuation phase (CP); isoniazid,
rifampin and ethambutol were prescribed for the next 4 months with
regular monitoring and follow-up. On follow up, continuation phase has
been extended further 6 month and hence total duration of ATT was total
12 months. Patient was on antibiotics for 2 weeks of post-op and 3 days
of pre-op.